CNN Exclusive: Prescriptions for popular diabetes and weight-loss drugs soared, but access is limited for some patients
By Deidre McPhillips, CNN (CNN) — As prescriptions for Ozempic soar, the drug and others like it are still reaching only a fraction of the population who could benefit from taking them — and the limited supply is disproportionately reaching White patients. The US Food and Drug Administration has approved two injectable semaglutide medications, which
Continue Reading